Gala GLP-1’s advertised prices are not interchangeable offers. The $179 monthly starting price for compounded treatment is tied to a yearly subscription; the homepage’s $199 monthly starting price requires a three-month plan. Ozempic has a different cash-price starting point altogether. For someone budgeting for care, the important comparison is therefore not simply $179 versus $199. It is the selected medication, the subscription commitment, the amount collected at enrollment and the obligations that remain if treatment or membership ends.
This documentary review examines Gala’s published materials consulted October 19, 2026. Gala is a platform operated by AI Coaching Inc., not a medical practice or pharmacy. Independent clinical practices provide care, and third-party pharmacies dispense prescriptions. Its advertised package combines medication access, a provider visit, shipping and support, but the subscription policy leaves some inclusions variable. The strongest reason to pause before paying is not an absent price: it is the gap between clear promotional starting prices and less-clear plan-specific billing and refund details.
At a glance
- Compounded annual-plan starting price
- Compounded GLP-1 treatment is advertised from $179 per month with a yearly subscription, all doses included, a provider visit and free shipping.Sources: [11]
- Separate three-month offer
- The homepage advertises treatment starting at $199 per month with a three-month plan; final pricing depends on the selected medication and plan at checkout.Sources: [9]
- Branded medication price
- Ozempic is advertised from $1,299 per month as a cash price, with possible insurance reductions, a provider visit and free shipping.Sources: [13]
- First charge
- The subscription policy says membership begins when the intake form is completed, when the first month is charged.Sources: [12]
- Cancellation deadline
- Cancellation requests must be received at least 72 hours before the billing date; missing that deadline triggers the next charge and delays cancellation until the subsequent billing date.Sources: [12]
Read the price as a plan offer, not a universal monthly rate
Gala’s compounded GLP-1 product listing advertises treatment from $179 per month with a yearly subscription. It lists all doses, a provider visit and free shipping as included, alongside FSA and HSA acceptance. The catalog describes the compounded choices as semaglutide or tirzepatide given by weekly injection. That starting price should not be extended to every medication or subscription option: Gala’s homepage expressly says final pricing depends on the medication and plan selected at checkout.
The homepage presents a separate starting price of $199 per month with a three-month plan. Meanwhile, the tirzepatide information page describes compounded GLP-1/GIP treatment, including tirzepatide, as $199 per month with medical evaluation and ongoing support, then displays a “Start for $179/mo” invitation without explaining the commitment there. These are meaningful differences in presentation, not enough evidence to identify one universally available tirzepatide rate or to label either amount a temporary introductory discount.
The useful next step is a product-specific quote that names the formulation, route, subscription term and collection schedule. Gala’s supplied materials do not establish the total initial outlay or prepayment arrangement for the yearly offer. A yearly subscription also does not, by itself, establish how much medication arrives in each shipment. Our guide to the first GLP-1 payment explains why the advertised monthly equivalent and the amount charged today need separate confirmation.
| Offer | Published price and inclusions | Condition or unresolved detail |
|---|---|---|
| Compounded yearly subscription | From $179/month; all doses, provider visit and free shipping | Yearly subscription; total first collection and early-exit treatment are not established |
| Homepage three-month plan | Starting at $199/month | Three-month plan; final medication and plan price determined at checkout |
| Tirzepatide information page | $199/month with evaluation and ongoing support; separate $179/month invitation | The lower invitation does not explain its commitment on that page |
| Ozempic | From $1,299/month cash; provider visit and free shipping | Insurance may reduce cost; individual coverage and final price require confirmation |
The first charge arrives at intake; the full renewal picture is less explicit
Gala’s subscription policy places the start of membership at completion of the intake form and says the first month is charged then. That makes the intake form a financial step, not merely an opportunity to ask clinical questions. Separately, Gala’s terms say prescriptions are entirely at a licensed provider’s discretion and are not guaranteed. Read together, these provisions mean a payment can precede a confirmed prescription, with medical-disqualification refunds governed by the separate refund language.
The general first-month provision does not fully resolve the advertised annual plan’s collection mechanics. The supplied documentation does not establish whether that particular offer involves additional upfront collection, how later charges are scheduled, or what happens financially after an early exit. It also does not provide a complete renewal-price schedule for each medication. Neither a price lock nor an automatic increase can be inferred from these omissions. The missing information is the actual plan-specific billing agreement.
Before submitting intake, ask for the amount charged immediately, the next charge date, the amount of that next charge and the financial consequences of leaving the selected term early. Request the same details if changing products or plans. Keep the offer and checkout terms together rather than relying on a headline screenshot alone. These questions distinguish recurring billing from a longer subscription commitment; our explanation of monthly and prepaid billing provides a framework for reading that distinction.
What the bundled price documents—and what it leaves variable
The compounded listing and Ozempic page both include a provider visit and free shipping. Gala also says a clinician-recommended higher dose is available at no additional cost, while its weight-loss page advertises all doses included. Those statements provide useful boundaries around two possible expenses: shipping and dose-related price increases. They do not establish that every medication has the same price, or that switching between compounded treatment and a branded product would leave the bill unchanged.
The subscription policy is broader and more qualified than the product cards. It says the single subscription price may include live consultations, electronic submissions and provider reviews, medication fulfilled through a pharmacy, laboratory services, care support and 24/7 patient support. It then states that covered services, labs and medications may vary. Consequently, the policy is not a reliable basis for assuming every laboratory test or every type of clinical interaction is included in every advertised package.
Gala says provider support continues for as long as the patient remains on treatment. Consultations may involve video or online messaging, depending on the patient, state law or medication, and later questions and adjustments may be handled through chat. The record does not establish a fixed follow-up schedule or clinician response time. Ask which visits, tests and communications your exact quote covers; what a program price includes is more useful than treating “all-included” as an unlimited-service promise.
Cancellation stops future service under rules; it does not promise money back
The product pages’ “Cancel anytime” language needs to be read alongside the subscription policy. Gala permits cancellation for any reason through customer service or, where available, the process in the online account. However, the request must be received at least 72 hours before the billing date. If it is late, Gala says the next billing charge will occur and cancellation will take effect on the subsequent billing date. Access continues through the end of the billing cycle.
Refund provisions require closer scrutiny. One passage promises a full refund if Gala’s medical provider disqualifies the patient for a medical reason. Another describes a refund of remaining subscription charges following disqualification and excludes refunds for other cancellations. A further provision limits approved refunds to the most recent billing cycle, excluding past cycles. The supplied wording does not explain consistently how those provisions interact for someone medically disqualified after paying for a longer plan.
For budgeting purposes, do not equate cancellation with reimbursement or assume unused annual-plan time is refundable. Obtain a written explanation for both an ordinary cancellation and medical disqualification under the specific plan being purchased. Use a cancellation channel that preserves the request and its receipt date, and ask for confirmation of the final billing date. Our guide to cancellation and refunds separates these issues, which Gala’s broad cancellation slogan does not settle by itself.
Ozempic has a separate cash-and-insurance calculation
Gala lists Ozempic, the Novo Nordisk semaglutide brand, from $1,299 per month as a cash price. The page includes a provider visit, free shipping, cancellation language and FSA/HSA acceptance, and says insurance may reduce the cost. This is a distinct branded offer, not another presentation of the compounded starting price. The “from” qualifier matters here too: the public page does not establish a final individualized charge or a complete schedule of future prices.
Insurance is not required to use Gala. For Ozempic specifically, Gala says it checks coverage during the assessment, describes coverage as sometimes available—especially with type 2 diabetes—and says coverage for weight loss alone is harder. Those are provider descriptions, not an insurer’s approval. NIDDK likewise notes that medication coverage varies by plan. The relevant financial answer is the insurer-confirmed responsibility for the particular prescription, rather than a general statement that insurance might help.
Two other catalog boundaries matter when comparing costs. Gala’s oral Wegovy page says availability is pending FDA approval and supply and invites visitors to a waitlist; it does not establish a currently purchasable option or a price. That is a report of Gala’s page, not an independent statement of current regulatory status. Gala also states that it is independent and unaffiliated with Novo Nordisk or Eli Lilly, so displaying their product names should not be read as manufacturer sponsorship.
Follow the payment through the platform, clinician and pharmacy
AI Coaching Inc. operates as Gala GLP-1. Its terms say Gala facilitates telehealth consultations but neither practices medicine nor operates as a pharmacy. The site attributes medical services to independently owned practices, including OpenLoop-affiliated medical groups and other affiliated practices, while Gala supplies administrative, technology and management services. This division matters when paying for a bundle: the company collecting or organizing payment is not necessarily the entity making the clinical decision or dispensing the prescription.
The advertised process begins with questions about the patient’s body, history and goals, followed by review of the full profile by a U.S.-licensed clinician. That clinician may prescribe or request clarification; approval is not guaranteed. Gala requires users to be at least 18 or the applicable age of majority. Its weight-loss marketing addresses women, while its semaglutide page describes possible BMI criteria. Those descriptions are not a substitute for individual review or proof of eligibility for every listed product.
If prescribed, medication is dispensed by a third-party pharmacy. Gala’s terms say the platform does not handle or ship medications. The supplied material does not identify the dispensing pharmacies by name or independently verify individual clinician or pharmacy licenses. Ask which clinical practice and pharmacy will serve you before paying, and who handles prescription questions versus billing disputes. Gala also says health information is shared with providers and partner pharmacies to facilitate clinically appropriate consultations and prescriptions.
Free shipping still leaves delivery and support responsibilities to clarify
Gala advertises access in all 50 states, free shipping and seven days from assessment to medication at the door. These are provider claims, not independently verified service guarantees. The seven-day statement describes the overall journey; it does not separately establish the clinical-review time, pharmacy preparation time or carrier transit time. Likewise, a nationwide access claim does not establish that every product is available to every patient in every state. Gala describes discreet delivery with refrigeration when needed.
The app provides access to medical visits, prescription renewals, communication with the medical team, appointment details and updates. It also displays shipments, previous orders and package tracking. Those tools can help distinguish an order being processed from a package actually moving, but they do not create a documented delivery guarantee. For order problems, Gala’s policy says a pharmacy may replace damaged items after receiving evidence of damage and will replace incorrect medications. It does not promise an automatic cash refund for either situation.
Gala advertises 24/7 patient support, but the documentation does not establish immediate clinician availability or a guaranteed response interval. The terms explicitly exclude urgent and emergency medical situations. A published support route is team@galaglp1.com; the terms also list an address at 1007 N Orange St., 4th Floor, Suite #2920, Wilmington, Delaware 19801. Before enrolling, establish whether support, the prescribing practice or the dispensing pharmacy should receive a delayed-delivery complaint, a medication question or a cancellation request.
Price does not establish product equivalence or treatment value
Gala acknowledges that compounded medications are not FDA approved and says it sources them from licensed compounding pharmacies. FDA explains that compounded preparations do not undergo its premarket review for safety, effectiveness and quality. Nonapproval alone is not proof of clinical inequivalence, but a low price does not establish equivalence either. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy.
That context changes the comparison from “Which monthly number is lower?” to “Which exact product is being proposed, why, and what care accompanies it?” NIDDK advises discussing benefits, side effects, health conditions, other medicines, family history and costs with a clinician. Follow-up concerns response and tolerance, not just a renewed charge. The supplied evidence does not establish Gala-specific clinical outcomes, so this review does not use drug-trial results or promotional testimonials to calculate the value of a Gala subscription.
Delivery quality is also separate from the shipping fee. FDA explicitly advises not using injectable GLP-1 medication that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. It also reports measurement and administration errors involving compounded products and advises clarifying instructions with the prescriber or pharmacist. These are general safeguards, not evidence of a Gala-specific incident. They reinforce why the pharmacy’s identity, contact route and instructions belong in the enrollment decision alongside the written price.
Questions & answers
Is Gala’s $179 monthly price a month-to-month offer?
The compounded product listing expressly ties that starting price to a yearly subscription. It includes all doses, a provider visit and free shipping, but does not establish the full initial collection or the financial treatment of leaving early. Do not assume the monthly display means either unrestricted month-to-month enrollment or mandatory payment of the entire year upfront.
When does Gala charge me if I have not yet received a prescription?
The subscription policy says the first month is charged when the intake form is completed and membership begins. Prescribing remains at the licensed provider’s discretion, and Gala does not guarantee a prescription. Its medical-disqualification refund language is therefore important; ask which refund provision applies to the selected plan before completing the paid enrollment step.
Will a higher prescribed dose increase Gala’s price?
Gala says a higher dose recommended by the provider is available at no additional cost, and its compounded offer lists all doses included. This documents a dose-related pricing claim, not a promise that changing medications or subscription plans costs nothing. Confirm that the statement applies to the exact product and plan shown in your checkout quote.
How early must I cancel to avoid another Gala charge?
Gala must receive the cancellation request at least 72 hours before the billing date. Otherwise, the policy says the next charge occurs and cancellation takes effect on the subsequent billing date. Request cancellation through customer service or the account process if available, retain confirmation, and distinguish stopping future charges from qualifying for a refund.
Does Gala’s Ozempic price assume insurance coverage?
No. The advertised starting price of $1,299 per month is described as a cash price, with insurance potentially reducing it. Gala says it checks coverage during assessment and that coverage for weight loss alone is harder. A provider visit and free shipping are listed as included; the published starting price does not establish your insurer’s approval or final responsibility.
Who should handle a damaged or incorrect Gala medication delivery?
Gala’s terms assign dispensing to third-party pharmacies, and its policy says the pharmacy may replace damaged items with evidence and will replace incorrect medications. Obtain that pharmacy’s contact information. If an injectable GLP-1 arrives warm or inadequately refrigerated, FDA advises not using it and contacting the provider or pharmacy; free shipping does not resolve a product-condition concern.
Our assessment
Gala publishes useful price anchors and several concrete inclusions: a provider visit, free shipping and a stated absence of extra charges for clinician-recommended higher doses. Its app, messaging options and third-party care structure are also described. The weaker area is the plan-specific financial agreement. The yearly offer’s initial collection and early-exit consequences remain unresolved, while medical-disqualification refund provisions are difficult to reconcile. For a cost-focused buyer, the sensible comparison is a written quote naming the exact medication, first charge, renewal schedule, included tests and cancellation consequences—not the lowest monthly headline alone. Gala may merit further consideration for someone seeking telehealth access, but the published materials do not support treating its starting price as a complete budget or its cancellation slogan as financial flexibility.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Gala GLP-1 — weight loss ↗
- Gala GLP-1 — weight loss/wegovy pill ↗
- Gala GLP-1 — gala glp1 app ↗
- Gala GLP-1 — tirzepatide for weight loss ↗
- Gala GLP-1 — terms and conditions ↗
- Gala GLP-1 — privacy policy ↗
- Gala GLP-1 — official website ↗
- Gala GLP-1 — semaglutide for weight loss ↗
- Gala GLP-1 — weight loss/compounded glp1 ↗
- Gala GLP-1 — refund policy ↗
- Gala GLP-1 — weight loss/ozempic ↗